Investor Presentation • Apr 23, 2024
Investor Presentation
Open in ViewerOpens in native device viewer

23rd April 2024
CEO Kjell Lorentsen CFO Rune Johansen
This document is not for release, publication or distribution, in whole or in part, directly or indirectly, in or into or from the united states of america, australia, canada, japan, hong kong or south africa or to any resident thereof or any other jurisdiction where such distribution is unlawful. This document is not an offer or an invitation to buy or sell securities.
This presentation (the "presentation") has been produced by gigante salmon as ("gigante salmon" or the "company") is for information purposes only and does not in itself constitute an offer to sell or a solicitation of an offer to buy any financial instruments. By attending a meeting where this presentation is presented, or by reading this presentation, you (the "recipient") agree to be bound by the following terms, conditions and limitations.
Neither the delivery of this presentation nor any further discussions with the recipient or any other person shall, under any circumstances, create any implication that there has been no change in the affairs of the company since the date of this presentation. The company does not undertake any obligation to review or confirm, or to release publicly or otherwise to the recipient or any other person, any revisions to the information contained in this presentation to reflect events that occur or circumstances that arise after the date of this presentation. The company does not intend to update the information after its distribution, even in the event the information becomes materially inaccurate.
This presentation includes and is based on, among other things, forward-looking information and statements. Such forward-looking information and statements are based on the current expectations, estimates and projections of the company or assumptions based on information available to the company. Such forward-looking information and statements are solely opinions and forecasts which reflect current views with respect to future events and are subject to risks, uncertainties and assumptions. None of the company or any of its representatives provides any assurance that the assumptions underlying such forward-looking statements are free from errors, nor do any of them accept any responsibility for the future accuracy of the opinions expressed in this presentation.
The information contained in this presentation is furnished by the company and has not been independently verified. No representation or warranty (express or implied) is made as to the accuracy or completeness of any information contained herein. None of the company, any representative acting on behalf of the company, or any of its respective parent or subsidiary undertakings or any such person's directors, officers, employees, advisors or representatives (collectively the "representatives") shall have any liability whatsoever arising directly or indirectly from the use of this presentation or otherwise arising in connection therewith, including but not limited to any liability for errors, inaccuracies, omissions or misleading statements in this presentation. The recipient acknowledges that it will be solely responsible for its own assessment of the company's business and the market, the market position and credit worthiness of the company. The recipient will be required to conduct its own analysis and accepts that it will be solely responsible for forming its own view of the potential future performance of the company, its business and the shares. The content of this presentation is not to be construed as legal, credit, business, investment or tax advice. The recipient should consult with its own legal, credit, business, investment and tax advisers as to legal, credit, business, investment and tax advice.

An overriding focus for all our activities is that the health of our colleagues and fish is crucial for our success: "If the fish are doing well, then we are doing well."
Important areas of responsibility for Gigante Salmon AS as the project's owner is undoubtedly health, environment, safety and quality.
None accidents with high potential of risk during Q1 2024.


Financing
The CAPEX increase of MNOK 350 compared to the last outlined CAPEX budget will be financed by the following three sources:

The private placement is expected to be completed by end of Q2 2024.













The date for completion of construction and testing is pushed from originally August 2023 to January 2024. Expected time to first harvest Q2 2025.


1 Includes financials costs


*The company has an agreement with Grytåga Settefisk AS on crediting for smolt that die in a given period after production startup. Test production of about 0.15 mill smolt is the amount of smolt the company is financially responsible for.
• Income statement reflects project execution phase, with limited income and operating expenses
| Income statement | Note | Q12024 | Q12023 | 2023 |
|---|---|---|---|---|
| Other income | - | 140 | 60 | |
| Total income | 140 | 60 | ||
| Employee benefits expense | 219 | 427 | 746 | |
| Depreciation and amortisation expenses | 1 | 25 | 25 | 100 |
| Other operating expenses | 289 | 891 | 2538 | |
| Total operating expenses | 533 | 1343 | 3 384 | |
| Net income | -533 | -1203 | -3324 | |
| Interest income | 862 | 1288 | 5 570 | |
| Other finance income | 27 | |||
| Interest expenses | 24 | |||
| Other financial expense | 46 | |||
| Stock exchange fees | 673 | 1207 | ||
| Net finances | 189 | 1288 | 4 319 | |
| Profit before income tax | -344 | 85 | බිමි විසින් මිතිවර්තිය හිමිය මිතිය මිතිය මෙම ප්රධාන අධිකරණය හිටි මෙම ප්රධාන අධිකරණය හිටි මෙම ප්රධාන අධිකරණය හිටි මෙම ප්රධාන අධික කිරීම සිට මධ්යා මිත කිරීම සිට මධ්යා මි | |
| Income tax expense | -62 | 30 | 267 | |
| Net profit or loss for the period | 2 | -282 | 55 | 728 |
| To minority interests | ||||
| To majority interests | -282 | 55 | 728 | |
| Disposal | ||||
| Transferred from/to equity | -282 | 55 | 728 | |

| Assets | Note | Q12024 | Q12023 | 2023 |
|---|---|---|---|---|
| Deferred tax asset | 7275 | 6048 | 7 213 | |
| Total intangible assets | 7275 | 6048 | 7 213 | |
| Land, buildings and other property | 530 962 | 165 567 | 514 079 | |
| Ships | 664 | 753 | 686 | |
| Right of use asset | 110043 | - | ||
| Fixtures/fittings, tools, office machinery and equipment | 10 | 21 | 13 | |
| Total tangible assets | 1 | 641679 | 166 341 | 514778 |
| Investments in shares | 100 | 100 | ||
| Total financial fixed assets | 100 | 100 | ||
| Total fixed assets | 649 054 | 172389 | 522 091 | |
| Inventory | 2852 | - | ||
| Trade receivables | 31 412 | 175 | - | |
| Other receivables | 29753 | 20647 | 20 595 | |
| Total receivables | 61165 | 20822 | 20595 | |
| Cash and bank deposits | 33072 | 129755 | 114 967 | |
| Total current assets | 97 089 | 150 577 | 135562 | |
| Total assets | 746143 | 322966 | 657 653 |
| Equity and liabilities | Note | Q12024 | Q12023 | 2023 |
|---|---|---|---|---|
| Share capital | 3 | 134 174 | 105556 | 134 174 |
| Share premium | 338 200 | 165 734 | 338 200 | |
| Total paid-in equity | 2 | 472 374 | 271290 | 472 374 |
| Other equity | 8860 | 8 469 | 9141 | |
| Total retained earnings | 2 | 8860 | 8469 | 9141 |
| Minority interests | ||||
| Total equity | 2 | 481 234 | 279759 | 481515 |
| Building loan | 155 858 | 542 | 130 436 | |
| Lease liabilities | 81 408 | |||
| Total other non-current liabilities | 237 266 | 542 | 130 436 | |
| Trade creditors | 18631 | 25069 | 33720 | |
| Public duties payable | 639 | 260 | 766 | |
| Other short-term liabilities | 8373 | 17334 | 11216 | |
| Total current liabilities | 27 643 | 42663 | 45702 | |
| Total liabilities | 264909 | 43205 | 176138 | |
| Total equity and liabilities | 746143 | 322966 | 657 653 |

• Total investments in the group in the first quarter rose 641 679 kNOK, compared to 514 778 kNOK in Q4
| Income statement | Note | Q12024 | Q12023 | 2023 |
|---|---|---|---|---|
| Other income | 140 | 140 | ||
| Total income | 140 | 140 | ||
| Depreciation and amortisation expenses | 1 | 22 | 22 | 90 |
| Other operating expenses | 8 | 156 | 248 | |
| Total operating expenses | 31 | 178 | 337 | |
| Net income | -31 | -38 | -197 | |
| Interest income | 408 | 628 | 2814 | |
| Other financial income | 27 | |||
| Interest expenses | 659 | 890 | ||
| Other financial expense | 24 | |||
| Net finances | -251 | 628 | 1927 | |
| Profit before income tax | -281 | 589 | 1730 | |
| Income tax expense | -62 | 131 | 383 | |
| Net profit or loss for the period | -220 | 458 | 1347 | |
| To minority interests | - | |||
| To majority interests | -220 | 458 | 1347 | |
| Disposal | ||||
| Transferred from/to equity | -220 | 458 | 1347 |

| Assets | Note | Q12024 | Q12023 | 31.12.2023 |
|---|---|---|---|---|
| Land, buildings and other property | 529873 | 164335 | 504190 | |
| Ships | 664 | 753 | 686 | |
| Right-of-use assets | 110043 | |||
| Total tangible assets | 1 | 640 580 | 165 088 | 504 877 |
| Total fixed assets | 640 580 | 165 088 | 504 877 | |
| Inventory | 2852 | |||
| Trade receivables | 34400 | 175 | ||
| Other receivables | 26522 | 20302 | 29 207 | |
| Total receivables | 60 922 | 20 477 | 29 207 | |
| Cash and bank deposits | 283333 | 52 492 | 68 353 | |
| Total current assets | 92 107 | 72969 | 97 560 | |
| Total assets | 732687 | 238 057 | 602436 |
| Equity and liabilities | Note | Q12024 | Q12023 | 31.12.2023 |
|---|---|---|---|---|
| Share capital | 35730 | 19230 | 35730 | |
| Share premium | 321370 | 172 870 | 321370 | |
| Total paid-in equity | 357 100 | 192100 | 357 100 | |
| Other equity | 3200 | 2531 | 3419 | |
| Total retained earnings | 3200 | 2531 | 3419 | |
| Total equity | 360 300 | 194 631 | 360 519 | |
| Deferred tax | 920 | 730 | 982 | |
| Liabilities to financial institutions | 155858 | 542 | 130 436 | |
| Liabilities to group companies | 106525 | 65867 | ||
| Lease liabilities | 81 408 | |||
| Total other non-current liabilities | 343 791 | 542 | 196 303 | |
| Trade creditors | 19421 | 25 079 | 33200 | |
| Public duties payable | 429 | 104 | 542 | |
| Other short-term liabilities | 7826 | 16971 | 108891 | |
| Total current liabilities | 27676 | 42 154 | 44633 | |
| Total liabilities | 372387 | 43 426 | 241918 | |
| Total equity and liabilities | 732687 | 238 057 | 602 436 |


Recommended as new chairperson of the board by the company's nomination committee



Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.